1-4 of 4
hepatosplenic candidiasis
Close
Sort by
Journal Articles

A Phase 1b Study of Panobinostat in Combination with Idarubicin and Ara-C in Patients with High-Risk Acute Myeloid Leukemia

Daniel J. DeAngelo, Alison R. Walker, MD, Richard F. Schlenk, MD, Jorge Sierra, Bruno C. Medeiros, MD, Enrique M. Ocio, Christoph Röllig, Stephen A. Strickland, MD, Felicitas Thol, MD, Sue-zette Valera, Antje Wegener, Tuli De, Song Mu, PhD, Florence Binlich, Robert K. Stuart, MD
Journal: Blood
Blood (2015) 126 (23): 2553.
https://doi.org/10.1182/blood.V126.23.2553.2553
Published: 2015
Journal Articles

Higher Infused Cell Dose Is Associated with a Decreased Risk of Invasive Fungal Infections After Allogeneic Hematopoietic Stem Cell Transplantation

Aazim Kamal Omer, MD, Panayiotis D Ziakas, MD, PhD, Theodora Anagnostou, MD, Themistoklis Kourkoumpetis, MD, Steven L. McAfee, MD, Bimalangshu R. Dey, MD, Eyal C. Attar, MD, Yi-Bin A. Chen, MD, Thomas R. Spitzer, MD, Eleftherios E Mylonakis, MD, Karen K. Ballen, MD
Journal: Blood
Blood (2012) 120 (21): 4134.
https://doi.org/10.1182/blood.V120.21.4134.4134
Published: 2012
Journal Articles

Factors Affecting Long-Term Survival in Non-Transplanted Acute Myeloid Leukemia Patients.

Anna H. Lof, Soren Lehmann, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4371.
https://doi.org/10.1182/blood.V110.11.4371.4371
Published: 2007
Journal Articles

Influence of Pretreatment with Amphotericin B on Treatement-Related Mortality (TRM) Following Allogeneic Stem Cell Transplantations.

Rudolf Trenschel, MD, Markus Ditschkowski, MD, Nina K. Steckel, MD, Michal Hlinka, MD, Ahmet Elmaagacli, MD, Helmut Ottinger, MD, Micheal Flasshove, MD, Dietrich W. Beelen, MD
Journal: Blood
Blood (2004) 104 (11): 5049.
https://doi.org/10.1182/blood.V104.11.5049.5049
Published: 2004